Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
about
Adeno-associated Virus as a Mammalian DNA VectorStructural Insights into Adeno-Associated Virus Serotype 5The structure of AAVrh32.33, a novel gene delivery vectorStructure of neurotropic adeno-associated virus AAVrh.8.Comparative analysis of adeno-associated virus capsid stability and dynamicsThe 2.8 Å Electron Microscopy Structure of Adeno-Associated Virus-DJ Bound by a Heparinoid Pentasaccharide.Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter.Characterization of naturally-occurring humoral immunity to AAV in sheep.In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy VectorThe threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene TherapySpecificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure.Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapyTargeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivoCapsid antibodies to different adeno-associated virus serotypes bind common regions.Humoral Immune Response to AAV.An emerging adeno-associated viral vector pipeline for cardiac gene therapyRecombinant adeno-associated virus vectors in the treatment of rare diseases.Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing.Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery VectorsAdeno-associated virus structural biology as a tool in vector development.Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.Structural Insights into Human Bocaparvoviruses.Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding SiteCopackaging of multiple adeno-associated viral vectors in a single production step.Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion.Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resinAdeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.Atomic Resolution Structures of Human Bufaviruses Determined by Cryo-Electron Microscopy.Recent progress and considerations for AAV gene therapies targeting the central nervous system.Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles.Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors
P2860
Q26782605-659C7980-3F07-45C2-BA5E-CC2A09C5EB8EQ27679454-761DA01D-97D3-45A3-A0BC-88DC347463DFQ27682946-7B2E3B2E-A922-465A-AE21-F50D57A477F3Q30152836-B98CC193-1252-4161-AA0E-B7D31EC9B68AQ30557598-E19B1180-BDCE-4672-91A2-6EF347AE47C3Q33633258-C28D2353-8A75-4BB5-A34C-864F5523940AQ34342494-1E3CB802-598B-4E1C-A144-14DA5096DB8BQ35005408-C2347266-F21D-4A09-AD40-4CAFDBE19623Q35952312-9EEDA5FE-445A-4C52-8E23-943566C63D39Q36155013-CC1FCECA-3D7E-47A1-87AC-1DFB12F9723CQ36406869-2EED914D-45C6-4012-9466-9DBF25C54431Q36476453-90A87C27-9A5C-4FD2-8725-072333DE2E5FQ37066314-B3C45D5F-B912-422B-A3BD-344FA1AC9484Q37066326-9A9F00EB-18AB-4C1C-833B-126EAD09E0BAQ37123344-6C71B95C-FBD3-497C-9911-74A249E36186Q37236099-8E0C314A-4C0F-4070-870F-1BF92B406B7EQ37272838-099D9315-31CD-4214-B731-B6D763E81AC0Q37279525-43EC6AE5-2CFE-475E-B2E4-77CCCE4593B5Q37614775-6EB32A0F-F389-4B26-84B0-CD8F643965DAQ38187651-5F618B83-E366-4366-B333-20C4D4648AF1Q38188560-8EC65A81-8F08-43D3-A3A3-769C1E4C9A9FQ38645275-69163866-C54A-430A-8FB7-81B01029127DQ38741334-6D0A8BED-7839-4DE6-B076-A1ADDD4EF48FQ38787435-F0D622C0-27F0-45EE-BAF5-094F0CA17145Q38964154-26C1B5A2-15F8-4FA0-B337-066E2C9A3F71Q39578007-0AF3C57C-45C4-4BF3-BC1A-DDC001F9E275Q40180004-A31D3354-E462-4006-B688-77A8FB96EFF3Q40611143-C05C143D-529C-489F-89F1-5327404A0125Q41098235-177CBBDF-1D95-4544-BF6A-3063A5D7764FQ41606960-11C1216C-2783-45BE-AB39-424BD4CB30A4Q47233169-016D78E4-DDB6-40E1-93A6-F91BB54FC04AQ54206545-800EDAB3-B14E-44E6-9021-B649E81532DAQ54210526-9AB794EB-BFEE-4307-A0F4-910E1DDDC81BQ55286992-E1729CBE-2DCC-49D8-A492-3F3067EF6689Q57469878-E0CBF1CA-09F6-4E5A-A326-76D707537732
P2860
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@ast
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@en
type
label
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@ast
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@en
prefLabel
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@ast
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@en
P2093
P2860
P356
P1433
P1476
Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.
@en
P2093
Brittney L Gurda
Christina Raupp
Jürgen A Kleinschmidt
Matthias Naumer
Norman H Olson
Robert McKenna
Ruth Popa-Wagner
Timothy S Baker
P2860
P304
P356
10.1128/JVI.00218-12
P407
P577
2012-05-16T00:00:00Z